Ibrutinib As A Bruton’S Kinase Inhibitor in the Management of Chronic Lymphocytic Leukemia: A New Agent with a Great Promise
Foluso, Ogunleye, Glick, Alexandra, Stender, Michael, Jaiyesimi, IshmaelLanguage:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.11.011
Date:
November, 2015
File:
PDF, 1.38 MB
english, 2015